Quantitation of human immunodeficiency virus in brains of demented and nondemented patients with acquired immunodeficiency syndrome

Annals of Neurology
R T JohnsonB W Chesebro

Abstract

We measured human immunodeficiency virus (HIV) DNA in brains of 15 patients who died with acquired immunodeficiency syndrome (AIDS). All had been followed prospectively prior to death; 7 were demented and 8 were not demented. HIV was detected in 13 of 15 brains by polymerase chain reaction (PCR) and in the remaining 2 by presence of viral RNA or viral antigen. Quantitative PCR showed a wide range in amounts of HIV DNA with no significant difference between brains of demented and nondemented patients. These results suggest that qualitative features of the virus, rather than increased virus load per se, may be responsible for the clinical differences between HIV-infected patients with and without dementia.

References

Jan 1, 1995·Current Topics in Microbiology and Immunology·C PowerB Chesebro
Nov 1, 1993·Neurology·J D GlassJ C McArthur
Jan 1, 1995·Clinical and Diagnostic Virology·L E BockstahlerR Brack-Werner

❮ Previous
Next ❯

Citations

Nov 1, 1996·Journal of Biomedical Science·D.L. Kolson, R.J. Pomerantz
Nov 2, 2005·Neurotoxicity Research·I P EverallE Masliah
Nov 30, 2000·Current Infectious Disease Reports·D B Clifford
Feb 5, 2004·Current Treatment Options in Neurology·Avindra Nath, Joseph Berger
Mar 14, 2002·The American Journal of Pathology·Stephanie J BisselClayton A Wiley
Feb 23, 2002·Molecular Immunology·Cornelia SpethPhilippe Gasque
Jun 4, 1998·Journal of Neuroimmunology·K GoodkinA M Kumar
Sep 1, 2001·Antiviral Research·M R RuffF A Ruscetti
Aug 9, 2002·The Journal of Biological Chemistry·Xiaojuan LiuKalipada Pahan
Nov 14, 1998·AIDS·R H EntingP Portegies
Nov 5, 1999·AIDS·C A WileyV Soontornniyomkij
Sep 10, 2002·AIDS·Julio Martín-GarcíaFrancisco González-Scarano
Dec 9, 1997·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·R K FujimuraP Shapshak
Dec 17, 2010·AIDS·Judith SchoutenPeter Portegies
Jan 1, 1997·Brain Pathology·M M Esiri
Mar 9, 2002·Journal of Virology·Cornelia SpethManfred P Dierich
Apr 15, 1999·Annual Review of Neuroscience·F González-Scarano, G Baltuch
Apr 7, 2010·Journal of Neurovirology·Susanna L LamersMichael S McGrath
Feb 23, 2002·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·C PowerR T Johnson
May 7, 2011·Molecular Immunology·Robert VeerhuisAndrea J Tenner
Dec 2, 2006·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Annelies Van RieKevin Robertson
Apr 27, 2005·Annals of Neurology·Jennifer E CookWilliam R Tyor
Mar 29, 2007·Brain Pathology·Francesco ScaravilliFrançoise Gray
Oct 26, 2013·The Lancet Infectious Diseases·David B Clifford, Beau M Ances
Mar 10, 2015·Journal of Neurovirology·Mamata MishraUdaykumar Ranga
Oct 19, 2011·PLoS Pathogens·Gretja SchnellRonald Swanstrom
Dec 6, 2000·Journal of Psychopharmacology·D McGuire, K Marder
Mar 29, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Marilyn S SmithOpendra Narayan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.